Pacira BioSciences
PCRX
PCRX
183 hedge funds and large institutions have $1.38B invested in Pacira BioSciences in 2016 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 77 increasing their positions, 40 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
59% less call options, than puts
Call options by funds: $5.63M | Put options by funds: $13.7M
Holders
183
Holding in Top 10
3
Calls
$5.63M
Puts
$13.7M
Top Buyers
| 1 | +$30.1M | |
| 2 | +$21.6M | |
| 3 | +$18.1M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$16.2M |
| 5 |
Millennium Management
New York
|
+$11.4M |
Top Sellers
| 1 | -$119M | |
| 2 | -$85.3M | |
| 3 | -$55.9M | |
| 4 |
Jennison Associates
New York
|
-$50.5M |
| 5 |
CCI
Columbus Circle Investors
|
-$40.5M |